Week 2_ Discussion NURS 6630
Respond to your colleague in one of the following ways:
· If your colleagues’ posts influenced your understanding of these concepts, be sure to share how and why. Include additional insights you gained.
· If you think your colleagues might have misunderstood these concepts, offer your alternative perspective and be sure to provide an explanation for them. Include resources to support your perspective.
**minimum of three (3) scholarly references are required for each reply cited within the body of the reply & at the end**
Reply # 1
Ozichukwu Awusah
Top of Form
Explain the agonist-to-antagonist spectrum of action of psychopharmacologic agents, including how partial and inverse agonist functionality may impact the efficacy of psychopharmacologic treatments.
In order to be effective, drugs must be able to reach their intended cells and attach to the appropriate receptors on those cells. It will be easier to explain how partial and inverse agonist function affects the effectiveness of therapies if you understand the distinction between the agonist and antagonist spectrum of action in relation to psychopharmacologic medicines. This receptor binding alters the activity or behavior of the cell by agonizing or antagonizing the cell's normal reaction, depending on the situation. Agonists are medications that function by activating the receptors in the body. The antagonist binds to the receptor without activating it, preventing the receptor from being triggered by additional agonists in the future. Full agonists give the greatest possible reaction since they bind to all of the accessible receptors. Partially agonists only bind to a subset of receptors, resulting in a reduced response even at larger concentrations of the agonist. Agonists constantly stimulate the receptors to produce a certain natural reaction, while the antagonist attempts to displace the agonist by blocking the agonist's route to the receptors and preventing it from reaching the receptors. Inverse agonists have the opposite effect of their agonist counterparts. According to pharmacological definition, an inverse agonist is a substance that binds to the same receptor as an agonist but produces the pharmacological response that is the inverse of the reaction produced by the agonist.
Compare and contrast the actions of g couple proteins and ion gated channels.
Both the G coupled protein receptors (GCPR) and the ion gated channels allow our cells to communicate with extracellular contents via specific integral receptors embedded into the cell membrane. When ligands bind to the receptor on an ion gated channel, there is a conversion of a chemical signal into an electrical one. As the channel opens it allows K+, Na+, Cl+, and Ca+ to move through the cell membrane and change its electrical properties. Thus, the ion gated channels produce a faster signal than the GCPRs. G-protein coupled receptors compromise the largest family of transmembrane proteins. They convey signals across the membrane in response to the binding of a particular ligand, resulting in the initiation of a cellular signaling cascade and the generation of an intracellular reaction. While the G protein is not the actual receptor, it is a protein that is connected to the receptor and that is activated by a particular ligand that binds to the receptor in order to transmit the activity inside the cell. The activation of an intracellular signaling cascade is induced by GCPRs.
Explain how the role of epigenetics may contribute to pharmacologic action.
It has long been understood that both environmental and genetic variables influence gene expression in different ways. It is the theory of epigenetics that genes may be activated or silenced depending on the presence or absence of certain chemical changes. The nucleotide sequence of the gene is not altered as a result of these variations in gene function. Epigenetics is a study that untangles the clues that suggested gene function and sequences that can be related to illnesses, behaviors, and other health indicators (Anderson et al.,2019). This includes an understanding of the influence of the phenotype of the DNA sequence. This research has found epigenetic mechanisms that are linked to cancers, cognitive dysfunction, respiratory, cardiovascular, reproductive, autoimmune, and neurobehavioral illnesses (Anderson et al.,2019). With this knowledge, pharmacologic action related to diseases linked with epigenetics can be created to regulate epigenetic mechanisms for the management of patients.
Explain how this information may impact the way you prescribe medications to patients. Include a specific example of a situation or case with a patient in which the psychiatric mental health nurse practitioner must be aware of the medication’s action.
Each mental disease and its relationship to psychopharmacology should be understood by psychiatric mental health nurse practitioners (PMHNP). A patient with a bipolar illness diagnosis should be extensively assessed in terms of family history, behaviors, and patient history. In terms of parents passing down this condition, family history plays a part in bipolar disorder. According to research, clinical differences between manic and depressive episodes may allow for the discovery of biomarkers that influence mood-stabilizers on the epigenome (Legrand, et. al., 2021). Although this has been detected, no precise indicators have been discovered, and further study is required. Patient behaviors should be examined in light of neurotransmitter abnormalities associated with the condition. Neurotransmitters such as serotonin, norepinephrine, dopamine, and GABA have been linked to bipolar illness. The lack of two neurotransmitters, serotonin, and norepinephrine, has been related to depression. Shi et al. (2008) Furthermore, dopamine agonists have been demonstrated to cause manic or severe depressive episodes while alleviating manic or depressed symptoms (Shi, et. al, 2008). GABA deficiencies have been associated with bipolar depressive episodes and stress-related depression behaviors in animal studies (Shi, et. al., 2008).
References
Anderson, E. M., Penrod, R. D., Barry, S. M., Hughes, B. W., Taniguchi, M., & Cowan, C. W. (2019). It
is a complex issue: emerging connections between epigenetic regulators in drug addiction?
The European Journal of Neuroscience, 50(3), 2477–2491
Camprodon, J. A., & Roffman, J. L. (2016). Psychiatric neuroscience: Incorporating pathophysiology into
clinical case formulation. In T. A. Stern, M. Favo, T. E. Wilens, & J. F. Rosenbaum. (Eds.),
Massachusetts General Hospital Psychopharmacology and neurotherapeutics (pp. 1–19).
Stefanska, B., & MacEwan, D. J. (2015). Epigenetics and pharmacology. British Journal of
Pharmacology, 172(11), 2701–2704. https://doiorg.ezp.waldenulibrary.org/10.1111/bph.13136
Legrand, A., Iftimovici, A., Khayachi, A., & Chaumette, B. (2021). Epigenetics in bipolar disorder: a
critical review of the literature. Psychiatric genetics, 31(1), 1– 12
https://doi.org/10.1097/YPG.0000000000000267
Shi, J., Badner, J. A., Hattori, E., Potash, J. B., Willour, V. L., McMahon, F. J., Gershon, E. S., & Liu, C.
(2008). Neurotransmission and bipolar disorder: a systematic family-based association study.
American journal of medical genetics. Part B, Neuropsychiatric genetics: the official publication
of the International Society of Psychiatric Genetics, 147B(7), 1270–1277.
https://doi.org/10.1002/ajmg.b.30769
Bottom of Form
Instructions:
Respond
to your
colleague
in one of the following ways:
·
If your colleagues’ posts influenced your understanding of these concepts, be sure to share
how and why. Include additional insights you gained.
·
If y
ou think your colleagues might have misunderstood these concepts, offer your alternative
perspective and be sure to provide an explanation for them. Include resources to support your
perspective.
*
*minimum of three
(3)
scholarly references are required for each
reply
cited
within the body of the reply & at the end
**
Reply
#
1
Ozichukwu
Awusah
Explain
the
agonist
-
to
-
an
tagonist
spectrum
of
action
of
psychopharmacologic
agents,
including
how
partial
and
inverse
agonist
functionality
may
impact
the
efficacy
of
psychopharmacologic
treatments
.
In
order
to
be
effective,
drugs
must
be
able
to
reach
their
intended
cells
and
attach
to
the
appropriate
receptors
on
those
cells.
It
will
be
easier
to
explain
how
partial
and
inverse
agonist
function
affects
the
effectiveness
of
therapies
if
you
understand
the
distinction
between
the
agonist
and
antagonist
spectrum
of
action
in
rela
tion
to
psychopharmacologic
medicines.
This
receptor
binding
alters
the
activity
or
behavior
of
the
cell
by
agonizing
or
antagonizing
the
cell's
normal
reaction,
depending
on
the
situation.
Agonists
are
medications
that
function
by
activating
the
receptors
in
the
body.
The
antagonist
binds
to
the
receptor
without
activating
it,
preventing
the
receptor
from
being
triggered
by
additional
agonists
in
the
future.
Full
agonists
give
the
greatest
possible
reaction
since
they
bind
to
all
of
the
accessible
receptor
s.
Partially
agonists
only
bind
to
a
subset
of
receptors,
resulting
in
a
reduced
response
even
at
larger
concentrations
of
the
agonist.
Agonists
constantly
stimulate
the
receptors
to
produce
a
certain
natural
reaction,
while
the
antagonist
attempts
to
disp
lace
the
agonist
by
blocking
the
agonist's
route
to
the
receptors
and
preventing
it
from
reaching
the
receptors.
Inverse
agonists
have
the
opposite
effect
of
their
agonist
counterparts.
According
to
pharmacological
definition,
an
inverse
agonist
is
a
subst
ance
that
binds
to
the
same
receptor
as
an
agonist
but
produces
the
pharmacological
response
that
is
the
inverse
of
the
reaction
produced
by
the
agonist
.
Compare
and
contrast
the
actions
of
g
couple
proteins
and
ion
gated
channels
.
Both
the
G
coupled
protein
receptors
(GCPR)
and
the
ion
gated
channels
allow
our
cells
to
communicate
with
extracellular
contents
via
specific
integral
receptors
embedded
into
the
cell
membrane.
When
ligands
bind
to
the
receptor
on
an
ion
gated
channel,
there
is
a
conversio
n
of
a
chemical
signal
into
an
electrical
one.
As
the
channel
opens
it
allows
K+,
Na+,
Cl+,
and
Ca+
to
move
through
the
cell
membrane
and
change
its
electrical
properties.
Thus,
the
ion
gated
channels
produce
a
faster
signal
than
the
GCPRs.
G
-
protein
coupl
ed
receptors
compromise
the
largest
family
of
transmembrane
proteins.
They
convey
signals
across
the
membrane
in
response
to
the
binding
of
a
particular
ligand,
resulting
in
the
initiation
of
a
cellular
signaling
cascade
and
the
generation
of
an
intracellu
lar
reaction.
While
the
G
protein
is
not
the
actual
receptor,
it
is
a
protein
that
is
connected
to
the
receptor
and
that
is
activated
by
a
particular
ligand
that
binds
to
the
receptor
in
order
to
transmit
the
activity
inside
the
cell.
The
activation
of
an
intracellular
signaling
cascade
is
induced
by
GCPRs
.
Explain
how
the
role
of
epigenetics
may
contribute
to
pharmacologic
action
.
It
has
long
been
understood
that
both
environmental
and
genetic
variables
influence
gene
expression
in
different
ways.
It
is
the
theory
of
epigenetics
that
genes
may
be
activated
or
silenced
depending
on
the
presence
or
absence
of
certain
Instructions:
Respond to your colleague in one of the following ways:
If your colleagues’ posts influenced your understanding of these concepts, be sure to share
how and why. Include additional insights you gained.
If you think your colleagues might have misunderstood these concepts, offer your alternative
perspective and be sure to provide an explanation for them. Include resources to support your
perspective.
**minimum of three (3) scholarly references are required for each reply cited
within the body of the reply & at the end**
Reply # 1
Ozichukwu Awusah
Explain the agonist-to-antagonist spectrum of action of psychopharmacologic agents, including how partial and
inverse agonist functionality may impact the efficacy of psychopharmacologic treatments.
In order to be effective, drugs must be able to reach their intended cells and attach to the appropriate receptors on
those cells. It will be easier to explain how partial and inverse agonist function affects the effectiveness of therapies if
you understand the distinction between the agonist and antagonist spectrum of action in relation to
psychopharmacologic medicines. This receptor binding alters the activity or behavior of the cell by agonizing or
antagonizing the cell's normal reaction, depending on the situation. Agonists are medications that function by activating
the receptors in the body. The antagonist binds to the receptor without activating it, preventing the receptor from being
triggered by additional agonists in the future. Full agonists give the greatest possible reaction since they bind to all of the
accessible receptors. Partially agonists only bind to a subset of receptors, resulting in a reduced response even at larger
concentrations of the agonist. Agonists constantly stimulate the receptors to produce a certain natural reaction, while
the antagonist attempts to displace the agonist by blocking the agonist's route to the receptors and preventing it from
reaching the receptors. Inverse agonists have the opposite effect of their agonist counterparts. According to
pharmacological definition, an inverse agonist is a substance that binds to the same receptor as an agonist but produces
the pharmacological response that is the inverse of the reaction produced by the agonist.
Compare and contrast the actions of g couple proteins and ion gated channels.
Both the G coupled protein receptors (GCPR) and the ion gated channels allow our cells to communicate with
extracellular contents via specific integral receptors embedded into the cell membrane. When ligands bind to the receptor
on an ion gated channel, there is a conversion of a chemical signal into an electrical one. As the channel opens it allows
K+, Na+, Cl+, and Ca+ to move through the cell membrane and change its electrical properties. Thus, the ion gated
channels produce a faster signal than the GCPRs. G-protein coupled receptors compromise the largest family of
transmembrane proteins. They convey signals across the membrane in response to the binding of a particular ligand,
resulting in the initiation of a cellular signaling cascade and the generation of an intracellular reaction. While the G
protein is not the actual receptor, it is a protein that is connected to the receptor and that is activated by a particular ligand
that binds to the receptor in order to transmit the activity inside the cell. The activation of an intracellular signaling
cascade is induced by GCPRs.
Explain how the role of epigenetics may contribute to pharmacologic action.
It has long been understood that both environmental and genetic variables influence gene expression in different ways. It
is the theory of epigenetics that genes may be activated or silenced depending on the presence or absence of certain